NSE - Delayed Quote INR

Windlas Biotech Limited (WINDLAS.NS)

Compare
930.30
-53.10
(-5.40%)
At close: 3:29:59 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
7,263,870
6,288,850
5,105,810
4,633,730
4,267,120
Cost of Revenue
4,538,180
3,961,750
3,254,470
3,028,160
2,744,050
Gross Profit
2,725,690
2,327,100
1,851,340
1,605,570
1,523,070
Operating Expense
2,051,910
1,679,820
1,372,100
1,199,680
1,079,800
Operating Income
673,780
647,280
479,240
405,890
443,270
Net Non Operating Interest Income Expense
-13,630
8,640
27,020
28,680
6,310
Pretax Income
815,670
770,910
570,390
455,650
217,400
Tax Provision
198,610
189,040
144,130
74,760
61,700
Net Income Common Stockholders
617,060
581,870
426,260
380,890
158,320
Diluted NI Available to Com Stockholders
617,060
581,870
426,260
380,890
158,320
Basic EPS
29.59
27.97
19.70
18.58
8.69
Diluted EPS
29.29
27.88
19.70
18.58
4.86
Basic Average Shares
20,858.31
20,806.29
21,635.92
20,497.17
18,220.71
Diluted Average Shares
21,079.35
20,872.75
21,635.92
20,497.17
32,584.09
Rent Expense Supplemental
--
4,850
3,920
4,380
400
Total Expenses
6,590,090
5,641,570
4,626,570
4,227,840
3,823,850
Net Income from Continuing & Discontinued Operation
617,060
581,870
426,260
380,890
158,320
Normalized Income
535,153
500,149.61
384,440.35
367,899.70
598,154.87
Interest Income
--
19,690
34,900
42,850
19,210
Interest Expense
33,320
11,050
7,880
14,170
12,900
Net Interest Income
-13,630
8,640
27,020
28,680
6,310
EBIT
848,990
781,960
578,270
469,820
230,300
EBITDA
1,080,850
916,400
701,910
591,290
359,950
Reconciled Cost of Revenue
4,538,180
3,961,750
3,254,470
3,028,160
2,744,050
Reconciled Depreciation
231,860
134,440
123,640
121,470
129,650
Net Income from Continuing Operation Net Minority Interest
617,060
581,870
426,260
380,890
158,320
Total Unusual Items Excluding Goodwill
108,270
108,270
55,960
15,540
-233,450
Total Unusual Items
108,270
108,270
55,960
15,540
39,190
Normalized EBITDA
972,580
808,130
645,950
575,750
320,760
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
26,363
26,549.61
14,140.35
2,549.70
-66,255.13
3/31/2021 - 8/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MAKERSL.BO Makers Laboratories Limited
139.95
+3.67%
 
SOLARA.NS Solara Active Pharma Sciences Limited
495.40
-3.38%
 
SAKAR.NS Sakar Healthcare Limited
236.04
-2.56%
 
WANBURY.NS Wanbury Limited
242.11
-1.94%
 
REMLIFE.BO Remedium Lifecare Limited
2.1000
-4.55%
 
HIKAL.NS Hikal Limited
390.20
-2.66%
 
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
202.88
-6.00%
 
BLISSGVS.NS Bliss GVS Pharma Limited
116.57
-3.18%
 
GUFICBIO.NS Gufic Biosciences Limited
310.05
-5.59%
 
ORCHPHARMA.NS Orchid Pharma Limited
720.35
-4.73%